bpc 157 + tb 500 BPC-157 TB-500 Blend | Public COA BPC-157 & TB-500 – Tissue

Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy

(2022) 8:eabn1382

Benefits: Fat Removal and Skin Tightening: SmartLipo removes stubborn fat deposits while tightening the skin, preventing the loose or deflated appearance sometimes associated with traditional liposuction

There was no evidence of dermatitis, cheilosis, stomatitis or glossitis on exam

Catching it early matters, because nerve damage that builds up over a long time doesnt always fully reverse, even after B12 levels come back up